Skip to content
Canada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-onlyCanada's trusted research peptide sourceFree shipping from $250 CADPurity-tested compoundsPay by Interac e-TransferCanadian owned & operatedFast, discreet shippingCOA-backed qualityCanada-only

GIP and GLP-1 receptor dual agonist · Research reagent

Tirzepatide 30mg

Targets GIP and GLP-1 receptors. Clinical trials in adults with type 2 diabetes measured blood-sugar control and body weight.

$168.99 CAD

· $5.63 / mg
Strength
Pack

Vial discount: 5% off at 3, 10% at 5, 20% at 10 eligible single vials, any mix. Applied automatically in the cart.

Interac e-Transfer

$9.99 shipping, free from $250 · Ships from Toronto · Canada only

Shipping and returns: Ships next business day from Toronto · $9.99 shipping, free from $250 · Arrives right or we make it right

For research use only. Not for human consumption.

Independent lab report

Lab report for this format available on request.

About Tirzepatide 30mg

Tirzepatide 30mg, also published as LY3298176, is catalogued here as: GIP and GLP-1 receptor dual agonist. Studied in adults with type 2 diabetes for blood-glucose and body-weight endpoints; GIP and GLP-1 are receptor targets, not independent product benefits. Targets GIP and GLP-1 receptors. Clinical trials in adults with type 2 diabetes measured blood-sugar control and body weight.

Human trial literature: SURPASS-1 randomized 478 adults in a 40-week phase 3 trial; all studied tirzepatide arms improved HbA1c and body-weight endpoints versus placebo. A defined type 2 diabetes population and manufactured trial intervention, not PLP material.

Human trial literature: Nausea, diarrhoea and vomiting were the most frequent adverse events, generally mild to moderate and transient. Trial monitoring and findings do not establish safety of a catalogue vial or pen.

When comparing published work, match the exact molecular identity, salt form and strength to the paper. Findings in cell or animal models describe those models only and do not establish outcomes in people. The reconstitution calculator converts vial content and diluent volume into concentration for laboratory preparation.

Proof Line Peptides lists Tirzepatide 30mg as a vial in 30 mg. Prices are shown in Canadian dollars, and orders ship from Toronto by tracked Canadian service.

A lab report for Tirzepatide 30mg is available on request. Proof Line Peptides does not display a report until it is matched to the exact compound and strength.

Shipped lyophilized (freeze-dried) and stable at room temperature in transit. Store sealed vials in the fridge or freezer on arrival. Once reconstituted, refrigerate. Anything not right? Our guarantee covers it.

Often studied alongside